Iridex (IRIX) Free Cash Flow Growth (5y) (2016 - 2026)
Iridex (IRIX) Free Cash Flow Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn |
| 10 | Iridex | 15.41 Mn | 10.81 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -16.23% |
| Sep 27, 2025 | -36.07% |
| Jun 28, 2025 | 29.10% |
| Mar 29, 2025 | 6.09% |
| Dec 28, 2024 | -48.30% |
| Sep 28, 2024 | -1.66% |
| Jun 29, 2024 | 0.32% |
| Mar 30, 2024 | 15.30% |
| Dec 30, 2023 | 13.38% |
| Sep 30, 2023 | 8.03% |
| Jul 1, 2023 | 13.06% |
| Apr 1, 2023 | -0.94% |
| Dec 31, 2022 | -10.59% |
| Oct 1, 2022 | -14.71% |
| Jul 2, 2022 | -41.86% |
| Apr 2, 2022 | -10.81% |
| Jan 1, 2022 | 82.46% |
| Apr 3, 2021 | 93.59% |
| Mar 28, 2020 | -33.85% |
| Sep 28, 2019 | -34.65% |